EHRLICH LEO 4
4 · Cellceutix CORP · Filed Jul 30, 2012
Insider Transaction Report
Form 4
Cellceutix CORPCTIX
EHRLICH LEO
DirectorChief Executive Officer10% Owner
Transactions
- AwardSwap
Stock Option (right to buy)
2010-12-29$0.11/sh+6,000,000$660,000→ 6,000,000 totalExercise: $0.11From: 2010-12-30Exp: 2020-12-30→ Common (6,000,000 underlying) - Other
Common
2010-07-27+1,000,000→ 8,745,002 total - AwardSwap
Common
2010-12-29$0.11/sh+6,000,000$660,000→ 18,000,000 totalExercise: $0.11From: 2012-01-03Exp: 2020-12-30→ Common (6,000,000 underlying) - AwardSwap
Stock Option
2010-12-29$0.11/sh+6,000,000$660,000→ 12,000,000 totalExercise: $0.11From: 2011-06-30Exp: 2020-12-30→ Common (6,000,000 underlying) - AwardSwap
Stock Option (right to buy)
2012-05-19$0.51/sh+2,000,000$1,020,000→ 20,000,000 totalExercise: $0.51From: 2012-11-18Exp: 2022-11-18→ Commom (2,000,000 underlying)
Holdings
- 2,752,310(indirect: By Spouse)
common
- 749,972(indirect: Daughter)
Common
Footnotes (2)
- [F1]1,000,000 shares was transferred by The Menon Family Trust
- [F2]Options were issued to Mr. Ehrlich in connection with renegotiating the terms of the outstanding loan balance as of March 31, 2012 of $2,248,037 represented by the Ehrlich Promissory Note C.